Free Trial

Frontline (FRO) Financials

Frontline logo
$18.74 +0.40 (+2.18%)
Closing price 03:59 PM Eastern
Extended Trading
$18.67 -0.07 (-0.35%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Frontline

Annual Income Statements for Frontline

This table shows Frontline's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Income / (Loss) Attributable to Common Shareholders
496 656 476 -15 413 140 -8.88 -265 117 155 149
Consolidated Net Income / (Loss)
496 656 476 -15 413 140 -8.40 -264 118 124 86
Net Income / (Loss) Continuing Operations
496 656 476 -15 413 140 -8.40 -264 118 255 137
Total Pre-Tax Income
503 657 476 -10 413 140 -8.08 -264 118 256 137
Total Operating Income
802 805 463 26 508 240 83 -196 177 287 121
Total Gross Profit
1,409 1,089 675 218 1,221 957 742 646 750 459 242
Total Revenue
2,183 1,881 1,442 776 1,221 957 742 646 754 459 242
Operating Revenue
2,183 1,881 1,442 776 1,221 957 742 646 754 459 242
Total Cost of Revenue
774 792 766 558 0.00 0.00 0.00 0.00 4.00 0.00 0.00
Operating Cost of Revenue
774 792 766 558 - - - - - - -
Total Operating Expenses
607 284 213 192 713 718 660 843 573 172 121
Selling, General & Admin Expense
36 54 47 26 44 45 37 38 37 11 4.94
Depreciation Expense
339 231 165 165 139 118 123 142 141 53 32
Other Operating Expenses / (Income)
232 - - - 530 555 500 386 333 109 84
Total Other Income / (Expense), net
-298 -148 13 -37 -95 -99 -91 -68 -60 -32 17
Interest & Investment Income
-3.41 23 58 7.68 -3.72 3.19 2.12 1.65 0.37 2.77 33
Other Income / (Expense), net
-295 -171 -45 -44 -19 -7.96 0.37 0.41 -3.30 -17 -8.91
Income Tax Expense
7.67 0.21 0.41 4.63 -0.01 0.31 0.32 0.29 0.35 0.15 0.00
Basic Earnings per Share
$2.23 $2.95 $2.22 ($0.08) $2.11 $0.81 ($0.05) ($1.56) $0.75 $1.29 $1.19
Weighted Average Basic Shares Outstanding
222.62M 222.62M 222.62M 203.53M 197.69M 196.89M 169.82M 169.81M 169.81M 781.94M 99.94M
Diluted Earnings per Share
$2.23 $2.95 $2.22 ($0.08) $2.09 $0.78 ($0.05) ($1.56) $0.75 $1.29 $1.19
Weighted Average Diluted Shares Outstanding
222.62M 222.62M 222.62M 203.53M 197.69M 196.89M 169.82M 169.81M 169.81M 781.94M 99.94M
Basic & Diluted Earnings per Share
$2.23 $2.95 $2.22 ($0.08) - - - - $0.75 $1.29 $1.19
Weighted Average Basic & Diluted Shares Outstanding
222.62M 222.62M 222.62M 203.53M 197.69M 196.89M 169.82M 169.81M 169.81M 781.94M 99.94M

Quarterly Income Statements for Frontline

No quarterly income statements for Frontline are available.


Annual Cash Flow Statements for Frontline

This table details how cash moves in and out of Frontline's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Change in Cash & Equivalents
105 54 141 -62 12 109 -37 -98 -62 -32 -51
Net Cash From Operating Activities
736 856 385 85 604 280 46 130 286 207 59
Net Cash From Continuing Operating Activities
751 881 530 82 604 280 46 130 286 214 58
Net Income / (Loss) Continuing Operations
496 656 476 -15 413 140 -8.40 -264 118 255 137
Consolidated Net Income / (Loss)
496 656 476 -15 413 140 -8.40 -264 118 124 86
Depreciation Expense
339 231 165 165 139 118 123 142 141 53 32
Non-Cash Adjustments To Reconcile Net Income
163 137 25 -9.36 5.77 22 -32 249 48 -92 -40
Changes in Operating Assets and Liabilities, net
-246 -144 -135 -59 45 -3.93 -39 1.87 -16 -4.56 -23
Net Cash From Investing Activities
-483 -1,235 -257 -374 -716 -191 -199 -723 -396 -459 -64
Net Cash From Continuing Investing Activities
-483 -1,235 -257 -374 -716 -191 -199 -723 -396 -148 132
Purchase of Property, Plant & Equipment
-915 -1,631 -336 -474 -724 -194 -216 -714 -622 -787 -202
Sale of Property, Plant & Equipment
432 143 80 80 25 0.00 0.00 - - - -
Sale and/or Maturity of Investments
0.00 252 0.00 14 0.00 0.00 - - - - -
Other Investing Activities, net
0.00 1.39 -1.51 0.00 -2.25 3.00 -0.66 -36 226 638 277
Net Cash From Financing Activities
-148 433 13 228 124 20 116 494 49 220 -46
Net Cash From Continuing Financing Activities
-148 433 18 228 124 20 116 494 49 78 -163
Repayment of Debt
-1,881 -537 -600 -229 -949 -205 -183 -119 -241 -546 -199
Payment of Dividends
-434 -639 -33 0.00 -312 -20 -0.39 -51 -165 -39 -37
Issuance of Debt
2,167 1,609 651 404 1,377 146 299 684 356 660 124

Quarterly Cash Flow Statements for Frontline

No quarterly cash flow statements for Frontline are available.


Annual Balance Sheets for Frontline

This table presents Frontline's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Assets
6,221 5,883 4,768 4,107 3,912 3,698 3,078 3,134 2,966 2,883 2,502
Total Current Assets
826 728 881 333 378 448 308 322 384 467 437
Cash & Equivalents
414 308 255 113 175 174 66 104 202 265 236
Accounts Receivable
137 144 153 85 77 104 79 72 74 97 36
Inventories, net
137 135 107 81 58 67 69 62 38 26 19
Other Current Assets
140 156 170 14 2.73 78 65 38 45 53 107
Plant, Property, & Equipment, net
0.00 0.00 48 131 48 46 91 331 308 960 227
Total Noncurrent Assets
5,372 4,767 3,785 166 184 3,203 2,671 2,481 2,274 1,455 1,838
Long-Term Investments
12 12 16 0.56 1.28 4.93 6.25 0.00 - - 59
Goodwill
112 112 112 112 112 112 112 112 225 225 0.00
Other Noncurrent Operating Assets
5,248 4,642 3,657 53 71 3,075 2,542 2,347 1,482 1,189 1,774
Total Liabilities & Shareholders' Equity
6,221 5,883 4,768 4,107 3,912 3,698 3,078 3,134 2,966 2,883 2,502
Total Liabilities
3,881 3,605 2,509 2,465 2,307 2,188 1,914 1,946 1,467 1,437 1,054
Total Current Liabilities
596 409 392 287 322 848 214 222 183 242 237
Short-Term Debt
460 262 278 199 235 439 120 156 124 147 44
Accounts Payable
134 146 113 80 75 33 41 21 22 38 6.00
Other Current Liabilities
1.15 1.10 1.02 8.72 12 300 16 6.07 10 20 175
Total Noncurrent Liabilities
3,285 3,196 2,117 2,178 1,985 1,339 1,699 1,724 1,284 1,195 817
Long-Term Debt
3,284 3,194 2,112 2,133 1,928 1,254 1,610 1,467 915 746 474
Capital Lease Obligations
0.45 1.43 2.37 44 53 76 88 256 366 447 0.00
Other Noncurrent Operating Liabilities
0.45 0.47 2.05 0.99 3.74 8.62 1.18 1.33 3.11 2.84 344
Total Equity & Noncontrolling Interests
2,340 2,277 2,260 1,642 1,605 1,510 1,164 1,188 1,500 1,446 1,447
Total Preferred & Common Equity
2,341 2,278 2,260 1,643 1,605 1,510 1,164 1,187 1,500 1,446 1,124
Total Common Equity
1,337 1,274 1,256 638 601 1,510 1,164 1,187 1,500 1,446 1,124
Common Stock
827 827 827 652 600 594 368 367 365 891 1,018
Retained Earnings
507 446 429 -14 1.33 -155 -295 -273 34 81 156
Other Equity Adjustments
1.78 - - - - 1,071 1,090 1,090 1,100 474 0.00
Noncontrolling Interest
-0.47 -0.47 -0.47 -0.47 -0.47 0.23 0.42 0.32 0.17 0.06 324

Quarterly Balance Sheets for Frontline

No quarterly balance sheets for Frontline are available.


Annual Metrics And Ratios for Frontline

This table displays calculated financial ratios and metrics derived from Frontline's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Growth Metrics
- - - - - - - - - - -
Revenue Growth
16.05% 30.46% 85.93% -36.49% 27.56% 28.97% 14.84% -14.32% 64.36% 89.78% 80.60%
EBITDA Growth
-2.18% 48.36% 295.90% -76.61% 77.72% 70.13% 498.65% -116.82% -4.69% 121.36% 43.16%
EBIT Growth
-20.04% 51.74% 2,419.30% -103.68% 111.11% 178.73% 142.42% -212.45% -35.58% 141.84% 53.72%
NOPAT Growth
-1.89% 73.99% 2,418.17% -96.38% 112.48% 312.79% 142.14% -177.64% -38.35% 137.80% 83.58%
Net Income Growth
-24.50% 38.04% 3,278.51% -103.62% 195.03% 1,766.90% 96.82% -324.93% -5.52% 44.20% 24.11%
EPS Growth
-24.41% 32.88% 2,875.00% -103.83% 167.95% 1,660.00% 96.79% -308.00% -41.86% 44.20% 24.11%
Operating Cash Flow Growth
-13.99% 122.19% 351.94% -85.89% 115.59% 506.85% -64.62% -54.38% 37.94% 253.59% 156.56%
Free Cash Flow Firm Growth
281.16% 96.76% -3,552.81% -102.71% 7,414.49% -55.15% 126.10% -4,062.97% 98.47% -51.80% -257.84%
Invested Capital Growth
11.84% 22.05% 968.84% 38.89% -90.98% 6.74% -1.38% 8.90% 7.42% 53.88% 45.55%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
64.55% 57.91% 46.84% 28.09% 100.00% 100.00% 100.00% 100.00% 99.47% 100.00% 100.00%
EBITDA Margin
38.74% 45.96% 40.42% 18.98% 51.53% 36.98% 28.04% -8.08% 41.16% 70.97% 60.85%
Operating Margin
36.72% 42.79% 32.10% 3.38% 41.58% 25.02% 11.14% -30.37% 23.53% 62.58% 49.92%
EBIT Margin
23.21% 33.68% 28.96% -2.32% 40.03% 24.19% 11.19% -30.30% 23.09% 58.92% 46.23%
Profit (Net Income) Margin
22.70% 34.89% 32.98% -1.93% 33.82% 14.62% -1.13% -40.90% 15.58% 27.10% 35.67%
Tax Burden Percent
98.48% 99.97% 99.91% 144.86% 100.00% 99.78% 103.91% 100.11% 99.71% 48.67% 62.77%
Interest Burden Percent
99.33% 103.63% 113.98% 57.36% 84.48% 60.58% -9.73% 134.80% 67.67% 94.51% 122.91%
Effective Tax Rate
1.52% 0.03% 0.09% 0.00% 0.00% 0.22% 0.00% 0.00% 0.29% 0.06% 0.00%
Return on Invested Capital (ROIC)
14.78% 17.54% 20.48% 5.53% 30.18% 8.00% 1.99% -4.88% 6.81% 13.88% 8.78%
ROIC Less NNEP Spread (ROIC-NNEP)
5.09% 11.15% 24.70% 8.11% -45.67% 2.00% -1.83% -13.53% 1.53% -12.31% 3.56%
Return on Net Nonoperating Assets (RNNOA)
6.68% 11.39% 3.90% -6.45% -3.66% 2.47% -2.70% -14.79% 1.17% -5.28% 3.29%
Return on Equity (ROE)
21.47% 28.93% 24.37% -0.92% 26.52% 10.47% -0.71% -19.67% 7.98% 8.60% 12.07%
Cash Return on Invested Capital (CROIC)
3.60% -2.32% -145.30% -27.03% 197.10% 1.48% 3.38% -13.40% -0.35% -28.56% -28.31%
Operating Return on Assets (OROA)
8.37% 11.90% 9.41% -0.45% 12.85% 6.84% 2.67% -6.42% 5.96% 10.04% 5.78%
Return on Assets (ROA)
8.19% 12.33% 10.72% -0.37% 10.86% 4.13% -0.27% -8.67% 4.02% 4.62% 4.46%
Return on Common Equity (ROCE)
12.13% 16.13% 11.84% -0.35% 17.97% 10.47% -0.71% -19.67% 7.98% 7.63% 9.26%
Return on Equity Simple (ROE_SIMPLE)
21.17% 28.82% 21.04% -0.91% 25.73% 9.27% -0.72% -22.26% 7.84% 8.60% 7.68%
Net Operating Profit after Tax (NOPAT)
790 805 463 18 508 239 58 -137 177 287 121
NOPAT Margin
36.16% 42.78% 32.08% 2.37% 41.58% 24.97% 7.80% -21.26% 23.46% 62.55% 49.92%
Net Nonoperating Expense Percent (NNEP)
9.69% 6.40% -4.23% -2.58% 75.85% 5.99% 3.82% 8.64% 5.28% 26.19% 5.22%
Return On Investment Capital (ROIC_SIMPLE)
12.97% - - - - - - - - - -
Cost of Revenue to Revenue
35.46% 42.09% 53.16% 71.91% 0.00% 0.00% 0.00% 0.00% 0.53% 0.00% 0.00%
SG&A Expenses to Revenue
1.65% 2.85% 3.29% 3.41% 3.62% 4.70% 5.02% 5.82% 4.91% 2.31% 2.04%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
27.82% 15.12% 14.74% 24.71% 58.42% 74.98% 88.86% 130.37% 75.94% 37.42% 50.08%
Earnings before Interest and Taxes (EBIT)
507 634 418 -18 489 232 83 -196 174 270 112
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
846 865 583 147 629 354 208 -52 310 326 147
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.33 3.37 1.59 1.75 1.63 0.96 0.53 0.43 2.31 0.13 0.00
Price to Tangible Book Value (P/TBV)
2.55 3.69 1.75 2.13 2.00 1.03 0.59 0.48 2.72 0.15 0.00
Price to Revenue (P/Rev)
1.43 2.28 1.39 1.44 0.80 1.51 0.83 0.79 4.60 0.41 0.00
Price to Earnings (P/E)
6.29 6.53 4.20 0.00 2.37 10.31 0.00 0.00 29.63 1.21 0.00
Dividend Yield
13.92% 10.91% 1.53% 0.00% 34.17% 1.18% 0.00% 19.95% 23.68% 3.01% 0.00%
Earnings Yield
15.89% 15.31% 23.79% 0.00% 42.15% 9.70% 0.00% 0.00% 3.37% 82.92% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.14 1.47 1.00 8.74 10.76 0.98 0.81 0.77 1.73 0.50 0.00
Enterprise Value to Revenue (EV/Rev)
2.95 3.95 2.86 4.35 2.45 3.16 3.17 3.49 6.18 2.72 0.00
Enterprise Value to EBITDA (EV/EBITDA)
7.61 8.59 7.07 22.94 4.76 8.53 11.30 0.00 15.01 3.83 0.00
Enterprise Value to EBIT (EV/EBIT)
12.71 11.72 9.87 0.00 6.13 13.04 28.30 0.00 26.76 4.61 0.00
Enterprise Value to NOPAT (EV/NOPAT)
8.15 9.23 8.91 183.84 5.90 12.64 40.61 0.00 26.33 4.34 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
8.74 8.67 10.69 39.60 4.96 10.78 50.92 17.29 16.29 6.01 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
33.44 0.00 0.00 0.00 0.90 68.44 23.89 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.60 1.52 1.06 1.45 1.38 1.17 1.56 1.58 0.94 0.93 0.36
Long-Term Debt to Equity
1.40 1.40 0.94 1.33 1.23 0.88 1.46 1.45 0.85 0.82 0.33
Financial Leverage
1.31 1.02 0.16 -0.80 0.08 1.24 1.48 1.09 0.76 0.43 0.92
Leverage Ratio
2.62 2.35 2.27 2.47 2.44 2.53 2.64 2.27 1.99 1.86 2.71
Compound Leverage Factor
2.60 2.43 2.59 1.42 2.06 1.53 -0.26 3.06 1.34 1.76 3.33
Debt to Total Capital
61.54% 60.29% 51.43% 59.13% 57.99% 53.96% 60.97% 61.27% 48.36% 48.08% 26.34%
Short-Term Debt to Total Capital
7.56% 4.57% 5.97% 4.95% 6.15% 13.38% 4.04% 5.10% 4.27% 5.29% 2.24%
Long-Term Debt to Total Capital
53.98% 55.72% 45.46% 54.18% 51.85% 40.57% 56.93% 56.18% 44.10% 42.79% 24.10%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
-0.01% -0.01% -0.01% -0.01% -0.01% 0.01% 0.01% 0.01% 0.01% 0.00% 16.48%
Common Equity to Total Capital
21.96% 22.21% 27.00% 15.89% 15.74% 46.04% 39.02% 38.71% 51.63% 51.91% 57.18%
Debt to EBITDA
4.43 4.00 4.11 16.14 3.52 5.00 8.74 -36.00 4.52 4.11 3.52
Net Debt to EBITDA
3.93 3.63 3.64 15.35 3.20 4.45 8.34 -33.42 3.84 3.26 1.27
Long-Term Debt to EBITDA
3.88 3.70 3.63 14.79 3.15 3.76 8.16 -33.00 4.13 3.66 3.22
Debt to NOPAT
4.74 4.30 5.17 129.32 4.36 7.41 31.41 -13.68 7.94 4.67 4.29
Net Debt to NOPAT
4.20 3.90 4.59 123.00 3.97 6.60 29.97 -12.70 6.74 3.69 1.55
Long-Term Debt to NOPAT
4.16 3.97 4.57 118.50 3.90 5.57 29.33 -12.54 7.24 4.15 3.92
Altman Z-Score
1.26 1.56 1.32 0.46 1.00 0.67 0.43 0.07 1.96 0.68 0.00
Noncontrolling Interest Sharing Ratio
43.47% 44.24% 51.44% 61.82% 32.23% 0.02% 0.03% 0.02% 0.01% 11.19% 23.28%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.39 1.78 2.25 1.16 1.17 0.53 1.44 1.45 2.10 1.93 1.84
Quick Ratio
0.93 1.11 1.04 0.70 0.81 0.34 0.77 0.97 1.61 1.59 1.15
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
193 -106 -3,282 -90 3,316 44 98 -377 -9.06 -591 -389
Operating Cash Flow to CapEx
152.34% 57.51% 150.63% 21.65% 86.35% 144.75% 21.34% 18.29% 45.95% 26.35% 29.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 45.96 0.47 1.06 -5.40 -0.16 -33.52 -52.43
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 8.37 2.97 0.50 1.87 5.05 11.77 7.90
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 -1.32 0.92 -1.82 -8.35 -5.94 -32.88 -19.35
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.36 0.35 0.32 0.19 0.32 0.28 0.24 0.21 0.26 0.17 0.13
Accounts Receivable Turnover
15.52 12.67 12.11 9.55 13.46 10.45 9.84 8.88 8.86 6.90 6.55
Inventory Turnover
5.69 6.54 8.16 8.04 0.00 0.00 0.00 0.00 0.13 0.00 0.00
Fixed Asset Turnover
0.00 0.00 16.14 8.66 25.83 14.00 3.52 2.02 1.19 0.77 1.88
Accounts Payable Turnover
5.53 6.12 7.97 7.22 0.00 0.00 0.00 0.00 0.13 0.00 0.00
Days Sales Outstanding (DSO)
23.52 28.80 30.14 38.21 27.12 34.93 37.10 41.09 41.21 52.91 55.71
Days Inventory Outstanding (DIO)
64.17 55.85 44.74 45.37 0.00 0.00 0.00 0.00 2,896.32 0.00 0.00
Days Payable Outstanding (DPO)
66.05 59.64 45.81 50.55 0.00 0.00 0.00 0.00 2,767.07 0.00 0.00
Cash Conversion Cycle (CCC)
21.64 25.01 29.07 33.03 27.12 34.93 37.10 41.09 170.46 52.91 55.71
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
5,639 5,042 4,131 387 278 3,087 2,892 2,932 2,693 2,507 1,629
Invested Capital Turnover
0.41 0.41 0.64 2.33 0.73 0.32 0.25 0.23 0.29 0.22 0.18
Increase / (Decrease) in Invested Capital
597 911 3,745 108 -2,808 195 -41 240 186 878 510
Enterprise Value (EV)
6,438 7,424 4,120 3,377 2,995 3,020 2,351 2,256 4,660 1,247 0.00
Market Capitalization
3,119 4,287 1,999 1,118 980 1,444 615 511 3,467 186 0.00
Book Value per Share
$6.00 $5.72 $6.17 $3.23 $3.05 $8.89 $6.85 $6.99 $1.92 $12.87 $11.24
Tangible Book Value per Share
$5.50 $5.22 $5.62 $2.66 $2.48 $8.23 $6.19 $6.33 $1.63 $10.87 $11.24
Total Capital
6,085 5,735 4,653 4,017 3,821 3,280 2,983 3,067 2,904 2,786 1,965
Total Debt
3,745 3,458 2,393 2,375 2,216 1,770 1,819 1,879 1,405 1,340 518
Total Long-Term Debt
3,285 3,196 2,115 2,177 1,981 1,331 1,698 1,723 1,281 1,192 474
Net Debt
3,320 3,137 2,122 2,259 2,016 1,577 1,735 1,745 1,193 1,060 187
Capital Expenditures (CapEx)
483 1,489 256 394 700 194 216 714 622 787 202
Debt-free, Cash-free Net Working Capital (DFCFNWC)
277 273 513 129 93 -149 137 122 113 94 -28
Debt-free Net Working Capital (DFNWC)
691 581 767 244 291 39 215 256 325 373 244
Net Working Capital (NWC)
230 319 489 46 56 -400 94 100 201 225 200
Net Nonoperating Expense (NNE)
294 148 -13 33 95 99 66 127 59 163 34
Net Nonoperating Obligations (NNO)
3,299 2,765 1,871 -1,256 -1,327 1,577 1,728 1,745 1,193 1,060 182
Total Depreciation and Amortization (D&A)
339 231 165 165 140 122 125 144 136 55 35
Debt-free, Cash-free Net Working Capital to Revenue
12.69% 14.49% 35.56% 16.62% 7.61% -15.57% 18.51% 18.82% 15.01% 20.40% -11.52%
Debt-free Net Working Capital to Revenue
31.64% 30.88% 53.21% 31.51% 23.84% 4.11% 28.90% 39.61% 43.05% 81.23% 100.80%
Net Working Capital to Revenue
10.55% 16.95% 33.94% 5.90% 4.60% -41.75% 12.67% 15.41% 26.63% 49.12% 82.58%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.23 $2.95 $0.00 ($0.06) $2.11 $0.81 ($0.05) ($1.56) $0.75 $1.29 $0.00
Adjusted Weighted Average Basic Shares Outstanding
222.62M 222.62M 222.62M 203.53M 197.69M 196.89M 169.82M 169.81M 169.81M 781.94M 22.47M
Adjusted Diluted Earnings per Share
$2.23 $2.95 $0.00 ($0.06) $2.09 $0.78 ($0.05) ($1.56) $0.75 $1.29 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
222.62M 222.62M 222.62M 203.53M 197.69M 196.89M 169.82M 169.81M 169.81M 781.94M 22.47M
Adjusted Basic & Diluted Earnings per Share
$2.23 $2.95 $0.00 $0.00 $0.00 $0.00 ($0.05) ($1.56) $0.75 $1.29 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
222.62M 222.62M 222.62M 203.53M 197.69M 196.89M 169.82M 169.81M 169.81M 781.94M 19.99M
Normalized Net Operating Profit after Tax (NOPAT)
790 805 463 18 355 239 58 57 238 287 84
Normalized NOPAT Margin
36.16% 42.78% 32.08% 2.37% 29.11% 24.97% 7.80% 8.74% 31.61% 62.55% 34.94%
Pre Tax Income Margin
23.05% 34.90% 33.01% -1.33% 33.82% 14.65% -1.09% -40.85% 15.62% 55.68% 56.82%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 6.77 2.45 0.89 -2.81 3.07 15.34 15.07
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 7.04 2.53 0.62 -1.97 3.12 16.29 16.27
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 -2.92 0.40 -1.43 -13.03 -7.91 -29.31 -12.19
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 -2.66 0.48 -1.70 -12.19 -7.86 -28.36 -10.98
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
87.60% 97.34% 7.02% 0.00% 75.64% 14.26% -4.60% -19.45% 140.03% 31.54% 42.86%
Augmented Payout Ratio
87.60% 97.34% 7.02% 0.00% 75.64% 14.26% -4.60% -19.45% 140.03% 31.54% 101.29%

Quarterly Metrics And Ratios for Frontline

No quarterly metrics and ratios for Frontline are available.


Frequently Asked Questions About Frontline's Financials

When does Frontline's fiscal year end?

According to the most recent income statement we have on file, Frontline's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Frontline's net income changed over the last 10 years?

Frontline's net income appears to be on an upward trend, with a most recent value of $495.58 million in 2024, rising from $86.26 million in 2014. The previous period was $656.41 million in 2023. View Frontline's forecast to see where analysts expect Frontline to go next.

What is Frontline's operating income?
Frontline's total operating income in 2024 was $801.75 million, based on the following breakdown:
  • Total Gross Profit: $1.41 billion
  • Total Operating Expenses: $607.36 million
How has Frontline revenue changed over the last 10 years?

Over the last 10 years, Frontline's total revenue changed from $241.83 million in 2014 to $2.18 billion in 2024, a change of 802.8%.

How much debt does Frontline have?

Frontline's total liabilities were at $3.88 billion at the end of 2024, a 7.6% increase from 2023, and a 268.0% increase since 2014.

How much cash does Frontline have?

In the past 10 years, Frontline's cash and equivalents has ranged from $66.48 million in 2018 to $413.53 million in 2024, and is currently $413.53 million as of their latest financial filing in 2024.

How has Frontline's book value per share changed over the last 10 years?

Over the last 10 years, Frontline's book value per share changed from 11.24 in 2014 to 6.00 in 2024, a change of -46.6%.



This page (NYSE:FRO) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners